http://www.cnr.it/ontology/cnr/individuo/prodotto/ID103186
The endogenous inhibitor of eNOs asymmetric dimethilarginine (ADMA) is higher in CAPD than in HD patients. (Comunicazione a convegno)
- Type
- Label
- The endogenous inhibitor of eNOs asymmetric dimethilarginine (ADMA) is higher in CAPD than in HD patients. (Comunicazione a convegno) (literal)
- Anno
- 2005-01-01T00:00:00+01:00 (literal)
- Alternative label
Enia G, Panuccio V, Mallamaci F, Tripepi G, Rapisarda F, Fatuzzo P, Zoccali C. (2005)
The endogenous inhibitor of eNOs asymmetric dimethilarginine (ADMA) is higher in CAPD than in HD patients.
in XLII Congress of EDTA., Istanbul, 4-7 June
(literal)
- Http://www.cnr.it/ontology/cnr/pubblicazioni.owl#autori
- Enia G, Panuccio V, Mallamaci F, Tripepi G, Rapisarda F, Fatuzzo P, Zoccali C. (literal)
- Http://www.cnr.it/ontology/cnr/pubblicazioni.owl#note
- Nephrol Dial Transplant 2005;20(S5):v301. (literal)
- Titolo
- The endogenous inhibitor of eNOs asymmetric dimethilarginine (ADMA) is higher in CAPD than in HD patients. (literal)
- Prodotto di
- Autore CNR
Incoming links:
- Prodotto
- Autore CNR di
